Company Research Report: Strides Pharma Science Limited
Company Overview
Name
Strides Pharma Science Limited
Mission
With a differentiated B2C portfolio focused on attaining leadership, Strides aims to provide an unparalleled growth opportunity for its people and value creation opportunity for its stakeholders. The company strives to be the leading Indian pharma multinational with a reputation for the highest quality and integrity.
Founded
1990
Founder
Mr. Arun Kumar, a first-generation entrepreneur, is the Company’s Founder and Promoter Director.
Key People
- Mr. Arun Kumar: Executive Chairperson
- Mr. Badree Komandur: Managing Director and Group CEO
- Mr. Aditya Arun Kumar: Executive Director – Business Development
- Mr. Vikesh Kumar: Group CFO & Chief Investor Relations Officer
- Ms. Manjula Ramamurthy: Company Secretary
Headquarters
Strides House, Bilekahalli, Bannerghatta Road, Bangalore – 560076, Karnataka, India
Number of Employees
1,001-5,000 employees
Revenue
No information is available
Notable Achievements and Reputation
Strides Pharma Science Limited is among the world's largest manufacturers of soft gelatin capsules. The company is renowned for its high-value, complex generics, and world-class manufacturing and R&D capabilities.
Products
Overview
Strides operates primarily in the market segments of Pharma Generics, Branded Generics, and Institutional Business. It focuses on creating a comprehensive product portfolio that spans complex therapeutic segments and varied dosage forms.
Product Segments
1. Pharma Generics
- Key Regions: US, other regulated markets such as Europe, Australia, South Africa, and Canada
- Portfolio: Over 220 ANDAs, including:
- Tablets
- Soft Gelatin Capsules
- Topicals
- Oral Liquids
- Modified Release products
2. Branded Generics
- Key Markets: Africa and other developing countries
- Therapeutic Categories:
- Neuropathy
- Malaria
- Anemia
- [CNS, Cardiovascular, Diabetes, Dermatology, and Probiotics]
- Notable Brands: Renerve, Unibrol, Combiart, Duotab, Vitafer
3. Institutional Business
- Focus: Anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious diseases
- Key Customers: Global procurement agencies like USAID, Global Fund, PEPFAR, UNICEF, WHO
Manufacturing Facilities
Locations and Capabilities
- Bangalore, Karnataka, India
- Dosage formats: Tablets, Hard Gelatin Capsules, Soft Gelatin Capsules, Sachets, Liquids (Oral), Topicals (Ointment & Cream), Powders
- Regulatory Approvals: US-FDA, MHRA, ANVISA, TGA, WHO
- Puducherry, India
- Dosage formats: Tablets, Hard Gelatin Capsules, Sachets
- Regulatory Approvals: US-FDA, MHRA, ANVISA, Health Canada, WHO
- Chennai, India
- Dosage formats: Tablets, Hard Gelatin Capsules
- Regulatory Approvals: US-FDA
- Milan, Italy
- Dosage formats: Semi-solids, Ointments & Creams, Oral Liquids
- Regulatory Approvals: EU GMP
- Chestnut Ridge, New York, USA
- Dosage formats: Oral solids including controlled substances, Modified Release products, Liquids, Nasal sprays, Gels
- Regulatory Approvals: US-FDA
Key Features
- High-end manufacturing capabilities approved by global regulatory authorities
- Strong regulatory compliance and advanced quality standards
- Capability to manufacture varied dosage formats, including combi-packs, bi-layered tablets, etc.
- Focus on niche products and complex formulations
Recent Developments
Notable Updates
1. August 2024
- Scheme of Arrangement: Involving Strides, Steriscience, and Stelis and their respective shareholders.
- Notice of Shareholders Meeting: Issued.
2. July 2024
- Acquisition: Balance stake in Strides Global Consumer Healthcare Limited, UK.
- USFDA Approval: Continued GMP status for the facility in Alathur, Chennai.
3. May 2024
- USFDA Approval: For Sucralfate Oral Suspension, 1gm/10 mL
- Divestment Completion: of Eris Pharma GmbH, Germany
4. April 2024
- USFDA Approval: For Gabapentin Tablets USP, 600 mg, and 800 mg.
New Products and Features
Strides consistently adds new filings every year leveraging its R&D capabilities, creating a robust pipeline of generics across formats and therapeutic areas. Specific details on the latest product launches or added features were not available from the data provided.
Partnerships and Strategic Alignments
Global Partnerships
Strides collaborates with leading pharmaceutical companies for regulatory compliance, product innovation, manufacturing flexibilities, and leveraging its intellectual property in formulation technologies.
Key Strategic Alliances
- Regulatory Compliance: Strides partners with global procurement agencies like USAID, PEPFAR, WHO, etc., to deliver high-quality, affordable medicines.
Partnership Philosophy
Strides emphasizes delivering incremental value through partnering across the globe, establishing itself as a partner-of-choice for pharmaceutical enterprises expanding their global footprints.
This report is designed to provide a comprehensive overview of Strides Pharma Science Limited, elucidating its legacy, product portfolio, manufacturing prowess, recent developments, and partnership strategy without additional commentary.